مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

3,497
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COMPARISON OF DESIPRAMINE AND SERTRALINE IN THE TREATMENT OF DEPRESSION IN PATIENTS SUFFERING FROM ALZHEIMER DISEASE

Pages

  249-262

Abstract

 Background and Objectives: As DEPRESSION is a common comorbid disorder with ALZHEIMER disease, it is important to recognize treatments with more effective and less adverse effects. This study has been devised to comparatively evaluate the effects of DESIPRAMINE and SERTRALINE in this patients.Materials and Methods: In this single blind clinical trial study, during January 2005 to April 2008, 63 outpatients in Ibn-e-Sina and Ghaem University hospitals in Mashhad city (north eastern part of Iran) were randomly allocated to two groups: 29 cases were treated by DESIPRAMINE and 34 patients were treated with SERTRALINE (both 25mg/day and if needed up to 150 mg/day). Patients were assessed at 2, 4, 8 and 12th week by PDRS, HRDS and MMSE and side effects of medications.Results: Changes in mood with HRDS and CSDD have shown that SERTRALINE was effective in all weeks (p<0.05). In contrast, DESIPRAMINE had no therapeutic effect except in the 12th week according to HRDS scale (p<0.05). Differences between the groups were significant (p=0.02). Differences between daily activating scales regarding PDRS in 8th and 12th week in DESIPRAMINE group were statistically meaningful (p<0.05), but not in the SERTRALINE group and between the two groups. Also, cognitive changes by MMSE were not significant in the two groups and between the two groups.Conclusion: SERTRALINE is more effective than DESIPRAMINE in the treatment of DEPRESSION in patients who suffer from ALZHEIMER disease, but they are ineffective on cognitive problems.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    MOKHBER, N., AZARPAZHOOH, M.R., & TALAEI, A.. (2011). COMPARISON OF DESIPRAMINE AND SERTRALINE IN THE TREATMENT OF DEPRESSION IN PATIENTS SUFFERING FROM ALZHEIMER DISEASE. JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES, 9(4 (37)), 249-262. SID. https://sid.ir/paper/70862/en

    Vancouver: Copy

    MOKHBER N., AZARPAZHOOH M.R., TALAEI A.. COMPARISON OF DESIPRAMINE AND SERTRALINE IN THE TREATMENT OF DEPRESSION IN PATIENTS SUFFERING FROM ALZHEIMER DISEASE. JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES[Internet]. 2011;9(4 (37)):249-262. Available from: https://sid.ir/paper/70862/en

    IEEE: Copy

    N. MOKHBER, M.R. AZARPAZHOOH, and A. TALAEI, “COMPARISON OF DESIPRAMINE AND SERTRALINE IN THE TREATMENT OF DEPRESSION IN PATIENTS SUFFERING FROM ALZHEIMER DISEASE,” JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES, vol. 9, no. 4 (37), pp. 249–262, 2011, [Online]. Available: https://sid.ir/paper/70862/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button